Entera Bio outlined three near-term milestones: submission of a final Phase 3 protocol to FDA for EB613, its oral...

Liberation Bioindustries has reshuffled its leadership as it approaches the start-up of a 600,000-liter precision fermentation facility in Richmond,...

Novo Nordisk and Aspect Biosystems have restructured their 2023 collaboration, transferring select stem cell–derived islet and hypoimmune engineering technologies,...

BrightInsight has expanded its executive leadership team, appointing a new chief operating officer, a senior vice president overseeing market...

BrightInsight has expanded its executive bench, appointing Robert Zdon as chief operating officer, Eric Redline as senior vice president...

Avacta Therapeutics issued a year-end update signaling a pivotal 2026. The company’s tumor-activated Pre|CISION platform now has two programs...

Iovance Biotherapeutics has granted inducement stock options for 97,710 shares to 17 newly hired non-executive employees, priced at $2.22...

Virbac closed 2025 with €1.465 billion in revenue, up 7.9% organically at constant exchange rates and scope, with fourth-quarter...

Cosmos Health’s distribution arm, Cosmofarm, is accelerating its build-out in Greece. In 2025, the wholesaler added nearly 100 new...

Nasus Pharma reported positive interim Phase 2 data for NS002, an intranasal powder formulation of epinephrine for anaphylaxis, demonstrating...